0 item $0
view cart | checkout

Investor Contacts

investor contact banner

Investor Contacts at Dyesol

Dyesol's Investor Relations team is headed by Managing Director, Richard Caldwell.  Keeping shareholders informed remains a top priority for the Dyesol and there are many ways you can keep in touch:

Website

Return regularly to Dyesol's website for the latest information on our research and development, partnerships, materials, and equipment. Visit the Investor Centre for quick links to latest market announcements and share information.

Subscribe

Subscribe to Dyesol's email news alerts to receive company announcements in real time, as they happen. By subscribing you will also receive Dyesol's tri-monthly Aurora Newsletter with news, views, feature articles, pictures, and insights into the work underway at Dyesol.

Social Media

Increasingly social media is a way for many of us to stay connected with the things we are interested in, that is why you can now find Dyesol on Twitter. Follow @GreatcellSolar (English) and @DyesolLtd (German) for announcements, news, and insights into the work underway. You can also connect with us on LinkedIn : Greatcell Solar.

Keep your details up-to-date

We strongly encourage all shareholders to keep your contact details and email addresses up-to-date with our share registry, Computershare, and manage your email news subscriptions, to ensure you don't miss out on important announcements.

Contact us

For more information or to provide feedback, you are invited to contact the Dyesol Investor Relations team:

Australian and all international investors are welcome to contact:

Marine André, Dyesol Investor Relations Manager
PO Box 6212
3 Dominion Place
Queanbeyan, NSW 2620
Australia

Telephone +61 2 6299 1592

Fax             +61 2 6299 1698

Email:       mandre@greatcellsolar.com

German investor are welcome to contact our dedicated German support team:

Eva Reuter
Dr Reuter Investor Relations
Mendelstraße 11 48149 Münster
Deutschland

Germany Telephone: 
0049-251 / 980 1560

Email: 
e.reuter@dr-reuter.eu

Visit: SRI2 Capital Platform